Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-053480
Filing Date
2023-05-01
Accepted
2023-05-01 07:05:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2314189d2_defa14a.htm DEFA14A 51123
2 EXHIBIT 2.1 tm2314189d2_ex2-1.htm EX-2.1 642976
3 EXHIBIT 3.1 tm2314189d2_ex3-1.htm EX-3.1 5709
4 EXHIBIT 99.1 tm2314189d2_ex99-1.htm EX-99.1 75860
5 GRAPHIC tm2314189d2_ex99-1img001.jpg GRAPHIC 3537
6 GRAPHIC tm2314189d2_ex99-1img002.jpg GRAPHIC 3709
  Complete submission text file 0001104659-23-053480.txt   787003
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36080 | Film No.: 23869893
SIC: 2834 Pharmaceutical Preparations